AOBiome Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • 2ndary - Private

AOBiome Therapeutics General Information

Description

Developer of clinical-stage therapeutics intended for addressing a broad range of inflammatory conditions. The company's proprietary product candidates harness a single strain of class-defining, auto-regulating ammonia-oxidizing bacteria, a human commensal, enabling healthcare practitioners to produce well-understood and well-characterized biochemical compounds that are critical to human health.

Contact Information

Website
www.aobiome.com
Formerly Known As
NitroCell BioSciences
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 160 Alewife Brook Parkway
  • Suite 1008
  • Cambridge, MA 02138
  • United States
+1 (617)
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 160 Alewife Brook Parkway
  • Suite 1008
  • Cambridge, MA 02138
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AOBiome Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-May-2026 Completed Clinical Trials - Phase 3
8. Debt - General 23-Aug-2022 Completed Clinical Trials - Phase 3
7. IPO Cancelled Clinical Trials - Phase 3
6. Later Stage VC Completed Clinical Trials - Phase 3
5. Later Stage VC (Series C) 05-Jan-2017 Completed Clinical Trials - Phase 3
4. Early Stage VC 16-Sep-2015 Completed Clinical Trials - Phase 3
3. Early Stage VC 28-Aug-2014 Completed Clinical Trials - Phase 1
2. Angel (individual) 21-Mar-2013 $630K $630K Completed Clinical Trials - Phase 1
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view AOBiome Therapeutics’s complete valuation and funding history, request access »

AOBiome Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of clinical-stage therapeutics intended for addressing a broad range of inflammatory conditions. The company's
Drug Discovery
Cambridge, MA
15 As of 2023

Cerdanyola, Spain
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AOBiome Therapeutics Competitors (2)

One of AOBiome Therapeutics’s 2 competitors is Ability Pharma, a Private Equity-Backed company based in Cerdanyola, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Vicore Pharma Holding Formerly VC-backed Stockholm, Sweden
You’re viewing 2 of 2 competitors. Get the full list »

AOBiome Therapeutics Patents

  • 254

    Total Documents Applications and Grants

  • Total Patents Families

  • 46

    Granted

  • 31

    Pending

  • Expiring in next 12 mo

AOBiome Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023527759-A Preparation of ammonia-oxidizing microorganisms that can be stored at room temperature Pending 21-May-2020
CA-3184356-A1 Shelf- stable ammonia oxidizing microorganism preparations Pending 21-May-2020
EP-4153196-A2 Shelf- stable ammonia oxidizing microorganism preparations Pending 21-May-2020
EP-4153196-A4 Shelf- stable ammonia oxidizing microorganism preparations Pending 21-May-2020
US-20230201274-A1 Shelf- stable ammonia oxidizing microorganism preparations Inactive 21-May-2020 A61K35/74
To view AOBiome Therapeutics’s complete patent history, request access »

AOBiome Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

AOBiome Therapeutics FAQs

  • When was AOBiome Therapeutics founded?

    AOBiome Therapeutics was founded in 2013.

  • Where is AOBiome Therapeutics headquartered?

    AOBiome Therapeutics is headquartered in Cambridge, MA.

  • What is the size of AOBiome Therapeutics?

    AOBiome Therapeutics has 15 total employees.

  • What industry is AOBiome Therapeutics in?

    AOBiome Therapeutics’s primary industry is Drug Discovery.

  • Is AOBiome Therapeutics a private or public company?

    AOBiome Therapeutics is a Private company.

  • What is AOBiome Therapeutics’s current revenue?

    The current revenue for AOBiome Therapeutics is .

  • How much funding has AOBiome Therapeutics raised over time?

    AOBiome Therapeutics has raised $105M.

  • Who are AOBiome Therapeutics’s competitors?

    Ability Pharma and Vicore Pharma Holding are competitors of AOBiome Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process